Sleep hormone melatonin put to the test against lupus fatigue and inflammation

NCT ID NCT07721324

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This trial investigates whether taking melatonin before bed can improve sleep quality, reduce fatigue, and lower inflammation in adults with active lupus. Sixty-four participants will either receive standard care plus melatonin or standard care alone for 12 weeks. Researchers will measure changes in blood markers of inflammation and oxidative stress, as well as sleep and quality of life scores.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
melatonin, a hormone that regulates sleep, given as an oral tablet (15 mg/day) for 12 weeks
What this could lead to
If it works, melatonin could become a simple, low-cost way to improve sleep, reduce fatigue, and lower inflammation in people with lupus.
What could go wrong
This is a small, early-stage trial. Melatonin may not significantly affect lupus symptoms or inflammation, and side effects like drowsiness or dizziness are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for THERAPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Fatigue Inflammation systemic lupus erythematosus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Rheumatology Ain Shams University hospitals

    Cairo, Egypt

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.